Chiltern Appoints Susan Romberg As Vice President, Global Clinical Development

May 14, 2014, 10:42 ET from Chiltern

LONDON and WILMINGTON, N.C., May 14, 2014 /PRNewswire/ -- Chiltern International Limited (Chiltern), a global contract research organization (CRO), today announced the appointment of Susan Romberg as Vice President, Global Clinical Development. With more than 20 years industry experience, Ms. Romberg joins Chiltern as a driver in building and managing high performing teams. She joins Chiltern's global leadership team to oversee clinical operations across the Americas, providing oversight and strategy development to support the acquisition of new business.  Ms. Romberg also sits on the Executive Steering Committee for the PharmaTimes Clinical Researcher of the Year competition. 

Aize Smink, Chief Operating Officer of Chiltern stated: "We are very excited to have Susan Romberg join Chiltern to oversee our Global Clinical Development in the US.  Susan brings a wealth of experience and strong executive leadership skills. Susan will further expand our US operations building on the strong relationships we have established in providing R&D services for our clients."

Susan has previously worked at Chiltern in Operations and has served in various roles across the industry. "Mid-size CROs have the ability to be flexible, adapting to our customers' needs, while ensuring quality deliverables and innovation solutions," commented Ms. Romberg. She went on to express, "Chiltern has an excellent reputation as a partner to the pharmaceutical industry. I'm looking forward to working closely with our talented and experienced team, and with our clients to bring new drugs to the market in the most effective manner possible."

Company profile

About Chiltern:

Established in 1982, Chiltern is a leading global clinical CRO with extensive experience in the management of Phase I-IV clinical trials across a broad range of therapeutic areas, functional service provision and contract staffing solutions. Chiltern has conducted trials in more than 40 countries, employs more than 1,600 people globally and offers services in Global Clinical Development, Global Scientific Services, and Global Resourcing Solutions. Chiltern prides itself as a development partner that offers innovation, responsiveness and quality delivery.

Further information is available at:

For more information contact:
Nicholas Spittal
Sr. Director, Global Commercial Affairs
Chiltern International Inc.
2528 Independence Blvd. Suite 101
Wilmington, NC 28412
Tel:  +1 (910) 338 4760


SOURCE Chiltern